Rx Advertising: Can Consumers And Doctors Tell When Drug Promos Are Deceptive?

US FDA to assess whether consumers and healthcare professionals can detect and report false or misleading promotions; Bad Ad program could be expanded to consumers.

FDA entrance sign 2016

The US FDA’s latest direct-to-consumer prescription drug advertising research project could lead to the creation of a program to encourage consumers to report deceptive promotions to the agency.

FDA announced the research project, “Consumer and Healthcare Professional Identification of and Responses to Deceptive Prescription Drug Promotion,” in a...

More from Marketing & Advertising

More from Compliance